Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Switzerland’s Galderma today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...

Bellatox Boutique Photo Julie Bella Robbins Photo Bellatox Boutique Wins Top Injector Practice and Top 1% Galderma Account in the Ae ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is now ...

Ad hoc announcement pursuant to Art. 53 LR This approval from the European Commission is based on robust results from the phase III OLYMPIA and ...

Evolus said on Thursday the U.S. Food and Drug Administration has approved its two new anti-wrinkle injectable gels, expanding the company's product portfolio beyond its cosmetic injection Jeuveau.

The FDA has approved Evolysse Form and Evolysse Smooth injectable hyaluronic acid gels, two dermal fillers from Evolus, the company announced in a press release.Both products are approved for use in ...

HBX said the value of stock sold on the Madrid stock exchange was up to €860mn depending on the exercise of an overallotment ...

John S. Barbieri, MD, MBA, FAAD, Director, Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital and an Assistant Professor of Dermatology at Harvard Medical School is the senior author of ...

As we wrap up the 2024 earnings reports, analysts weigh in on how beauty conglomerates should go about reinvigorating sales.

Individuals on immunosuppressants should discontinue them prior to patch testing, if at all possible, to avoid tarnishing the test results, according to updated guidelines from the North American ...